Your trusted destination for CME, CPD & Medical Education across the Middle East.
Cambridge Precision Medicine
Dr. Manuel Corpas is an internationally recognized computational biologist, personal genomics pioneer, entrepreneur, and global advocate for genomic and health data equity. He earned his PhD in Computational Biology from the University of Manchester. Early in his career, Dr. Corpas gained widespread international recognition for his pioneering open-data initiative in personal genomics—sequencing and openly publishing his own family’s complete genomic data to explore real-world interpretation bottlenecks.
Over two decades, Dr. Corpas has built a distinguished career bridging academic research, open-source bioinformatics infrastructure, and commercial precision medicine. He is the Founder of Cambridge Precision Medicine and Co-Founder & Chief Scientist of GENEQ Global. Previously, he served as Senior Scientist at Cambridge Epigenetix, Project Manager at the Wellcome Trust Sanger Institute, and Bioinformatician for the DECIPHER project—a globally used database for clinical microdeletion and rare disease interpretation.
A central focus of Dr. Corpas’s work is addressing the profound global imbalance in genomic and microbiome reference databases. Documenting that over 85% of global GWAS data originates from populations of European ancestry, he has spearheaded landmark initiatives such as the Peruvian Genome Project to map underrepresented indigenous populations. More recently, he has pioneered "agentic genomics" and developed open trust layers (such as ClawBio) to ensure that artificial intelligence (AI) models operating on multi-omics data maintain clinical safety, provenance, and population-level robustness. His scientific contributions span over 100 peer-reviewed articles, books, and software tools, including founding BioJS—the open standard for biological data visualization—and founding the International Society for Computational Biology (ISCB) Student Council.
At the MENA Microbiome Conference 2026, Dr. Corpas brings his multidisciplinary expertise in computational genomics, AI validation, and metagenomics to the international podium. His keynote presentation focuses on metagenomic surveillance of antimicrobial resistance (AMR). Addressing an audience of physicians, researchers, and bioinformaticians, he outlines how harmonized metagenomic workflows can distinguish mobile resistance genes across ancient, modern human gut, oral, and environmental microbiomes—providing actionable genomic surveillance frameworks tailored to the MENA population.

Sidra Medicine
Sidra Medicine